Story perspectives

Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal

11/6/2025

Summary

Kimberly-Clark Acquires Kenvue

Kimberly-Clark plans to acquire Kenvue, the Tylenol maker, in a cash-and-stock deal valued at $48.7 billion.
The merger would unite brands like Huggies, Kleenex, and Band-Aid and generate $32 billion in revenue.
Kenvue shareholders will receive $3.50 per share plus 0.14625 Kimberly-Clark shares, totaling $21.01 per Kenvue share.
The deal is expected to close in the second half of 2026, with Mike Hsu leading the combined company in Irving, Texas.

Summary

Paxton Sues J&J

Texas Attorney General Ken Paxton has filed a lawsuit against Kenvue and Johnson & Johnson, claiming they hid evidence linking Tylenol to neurodevelopmental disorders.
The lawsuit alleges that Kenvue was established to shield Johnson & Johnson from liability.
Kenvue's CEO, Kirk Perry, asserted the safety of their products despite ongoing litigation regarding talc and Tylenol.
Johnson & Johnson will indemnify Kenvue for U.S. liabilities, while Kenvue faces lawsuits in Britain.
Kimberly-Clark's CEO, Mike Hsu, noted that the company consulted experts regarding the acquisition amid these legal issues.

History

Historical Context

Johnson & Johnson's legal troubles regarding talc products began in 2006 when the International Agency for Research on Cancer classified talcum powder as a possible carcinogen. By 2020, the company agreed to pay $2.1 billion to settle claims linking its talc products to cancer. The ongoing lawsuits, now affecting its spinoff Kenvue, raise significant concerns about consumer safety and corporate accountability.

1 of 3

Kimberly-Clark Acquires Kenvue

Kimberly-Clark plans to acquire Kenvue, the Tylenol maker, in a cash-and-stock deal valued at $48.7 billion.
The merger would unite brands like Huggies, Kleenex, and Band-Aid and generate $32 billion in revenue.
Kenvue shareholders will receive $3.50 per share plus 0.14625 Kimberly-Clark shares, totaling $21.01 per Kenvue share.
The deal is expected to close in the second half of 2026, with Mike Hsu leading the combined company in Irving, Texas.

1 / 3